Page last updated: 2024-08-24

dexmedetomidine and Neoplasms

dexmedetomidine has been researched along with Neoplasms in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (23.08)	29.6817
2010's	3 (23.08)	24.3611
2020's	7 (53.85)	2.80

Authors

Authors	Studies
Cai, Q; Dou, Z; Gao, M; Guan, Y; Hu, Y; Huang, L; Liu, D; Liu, G; Wei, H	1
Atayee, RS; Byrne, JM; Edmonds, KP; Mesarwi, P	1
Anghelescu, DL; Baker, JN; Bhatia, S; Cuviello, A; Johnson, LM; Pasli, M	1
Cata, JP	1
Du, B; Guo, Q; Qi, X; Wang, B; Xiao, F; Zhang, H; Zhang, J	1
Abd El-Rahman, AM; AbdeLemam, RM; Fares, KM; Mohamed, SA; Osman, AMM	1
Ferguson, L; Hooper, S	1
Hato, A; Ikegaki, J; Kimura, Y; Komasawa, N	1
Gao, XZ; Jin, Y; Li, WY; Liu, HJ; Liu, XM; Xia, M	1
Coyne, PJ; Roberts, SB; Smith, TJ; Wozencraft, CP	1
Martins, MA; Naylor, C; Peixoto, G; Soares, LG	1
Boyaci, A; Gulcu, N; Ugur, F	1
Brodner, G; Buerkle, H; Möllhoff, T; Van Aken, H	1

Reviews

2 review(s) available for dexmedetomidine and Neoplasms

Article	Year
The Role of Dexmedetomidine in Tumor-Progressive Factors in the Perioperative Period and Cancer Recurrence: A Narrative Review. Drug design, development and therapy, 2022, Volume: 16 Topics: Adrenergic alpha-2 Receptor Agonists; Cytokines; Dexmedetomidine; Humans; Neoplasms; Perioperative Period	2022
[Efficacy of oncologic surgery. Does anesthesia influence the postoperative outcome?]. Zentralblatt fur Chirurgie, 2001, Volume: 126, Issue:4 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Anesthesia; Atenolol; Bisoprolol; Clinical Trials as Topic; Combined Modality Therapy; Contraindications; Dexmedetomidine; Hemodynamics; Humans; Imidazoles; Intraoperative Complications; Multicenter Studies as Topic; Neoplasms; Postoperative Complications; Preoperative Care; Risk Factors; Time Factors; Treatment Outcome	2001

Article

Year

The Role of Dexmedetomidine in Tumor-Progressive Factors in the Perioperative Period and Cancer Recurrence: A Narrative Review.

Drug design, development and therapy, 2022, Volume: 16

Topics: Adrenergic alpha-2 Receptor Agonists; Cytokines; Dexmedetomidine; Humans; Neoplasms; Perioperative Period

2022

[Efficacy of oncologic surgery. Does anesthesia influence the postoperative outcome?].

Zentralblatt fur Chirurgie, 2001, Volume: 126, Issue:4

Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Anesthesia; Atenolol; Bisoprolol; Clinical Trials as Topic; Combined Modality Therapy; Contraindications; Dexmedetomidine; Hemodynamics; Humans; Imidazoles; Intraoperative Complications; Multicenter Studies as Topic; Neoplasms; Postoperative Complications; Preoperative Care; Risk Factors; Time Factors; Treatment Outcome

2001

Trials

2 trial(s) available for dexmedetomidine and Neoplasms

Article	Year
Analgesic Effect of Intrathecal Fentanyl vs Dexmedetomidine as Adjuvants to Bupivacaine Following Abdominal Surgery for Cancer in Children, a Randomized Trial. Pain medicine (Malden, Mass.), 2020, 11-01, Volume: 21, Issue:11 Topics: Analgesics; Anesthetics, Local; Bupivacaine; Child; Dexmedetomidine; Double-Blind Method; Fentanyl; Humans; Neoplasms; Pain, Postoperative	2020
Effect of intrathecal dexmedetomidine on spinal morphine analgesia in patients with refractory cancer pain. Journal of palliative medicine, 2014, Volume: 17, Issue:7 Topics: Adult; Aged; Analgesics, Non-Narcotic; Analgesics, Opioid; Cross-Over Studies; Dexmedetomidine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections, Spinal; Male; Middle Aged; Morphine; Neoplasms; Outcome Assessment, Health Care; Pain Management; Pain Measurement; Pain, Intractable	2014

Article

Year

Analgesic Effect of Intrathecal Fentanyl vs Dexmedetomidine as Adjuvants to Bupivacaine Following Abdominal Surgery for Cancer in Children, a Randomized Trial.

Pain medicine (Malden, Mass.), 2020, 11-01, Volume: 21, Issue:11

Topics: Analgesics; Anesthetics, Local; Bupivacaine; Child; Dexmedetomidine; Double-Blind Method; Fentanyl; Humans; Neoplasms; Pain, Postoperative

2020

Effect of intrathecal dexmedetomidine on spinal morphine analgesia in patients with refractory cancer pain.

Journal of palliative medicine, 2014, Volume: 17, Issue:7

Topics: Adult; Aged; Analgesics, Non-Narcotic; Analgesics, Opioid; Cross-Over Studies; Dexmedetomidine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections, Spinal; Male; Middle Aged; Morphine; Neoplasms; Outcome Assessment, Health Care; Pain Management; Pain Measurement; Pain, Intractable

2014

Other Studies

9 other study(ies) available for dexmedetomidine and Neoplasms

Article	Year
Dexmedetomidine Continuous Infusion for Refractory Cancer Pain at End of Life: A Case Report. Journal of pain & palliative care pharmacotherapy, 2022, Volume: 36, Issue:3 Topics: Analgesics, Opioid; Cancer Pain; Death; Dexmedetomidine; Female; Humans; Middle Aged; Neoplasms; Pain, Intractable	2022
Dexmedetomidine and Propofol at End of Life in Pediatric Oncology: Trends in Palliative Sedation Therapy. Journal of palliative medicine, 2023, Volume: 26, Issue:1 Topics: Child; Death; Dexmedetomidine; Humans; Neoplasms; Pain; Palliative Care; Propofol; Prospective Studies; Terminal Care	2023
Dexmedetomidine for cancer surgery: A short-term infusion with long-term benefits. Or just another smoking mirror? Journal of clinical anesthesia, 2023, Volume: 87 Topics: Dexmedetomidine; Humans; Hypnotics and Sedatives; Neoplasms; Propofol; Smoking	2023
Clinical efficacy of sufentanil combined with dexmedetomidine in patient-controlled subcutaneous analgesia for advanced cancer pain. Pakistan journal of pharmaceutical sciences, 2023, Volume: 36, Issue:3(Special) Topics: Analgesia, Patient-Controlled; Cancer Pain; Dexmedetomidine; Humans; Neoplasms; Pain; Sufentanil; Treatment Outcome	2023
Dexmedetomidine withdrawal syndrome and opioid sensitivity. BMJ supportive & palliative care, 2023, Volume: 13, Issue:e1 Topics: Analgesics, Opioid; Dexmedetomidine; Humans; Neoplasms; Pain Management; Substance Withdrawal Syndrome	2023
[Three successful cases of continuous dexmedetomidine infusion for the treatment of intractable delirium associated with cancer pain]. Masui. The Japanese journal of anesthesiology, 2013, Volume: 62, Issue:12 Topics: Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Delirium; Dexmedetomidine; Fatal Outcome; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Pain, Intractable; Palliative Care; Treatment Outcome	2013
Dexmedetomidine as an adjuvant analgesic for intractable cancer pain. Journal of palliative medicine, 2011, Volume: 14, Issue:3 Topics: Analgesics, Non-Narcotic; Chemotherapy, Adjuvant; Dexmedetomidine; Female; Humans; Middle Aged; Neoplasms; Pain, Intractable	2011
Dexmedetomidine: a new option for intractable distress in the dying. Journal of pain and symptom management, 2002, Volume: 24, Issue:1 Topics: Adrenergic alpha-Agonists; Adult; Dexmedetomidine; Fatal Outcome; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Neoplasms; Pain, Intractable; Palliative Care	2002
Intrathecal infusion therapy with dexmedetomidine-supplemented morphine in cancer pain. Acta anaesthesiologica Scandinavica, 2007, Volume: 51, Issue:3 Topics: Aged; Analgesia, Epidural; Analgesics, Non-Narcotic; Analgesics, Opioid; Dexmedetomidine; Drug Therapy, Combination; Humans; Male; Morphine; Neoplasms; Pain; Recurrence	2007